Prognostic factors of locally advanced breast cancer patients receiving neoadjuvant and adjuvant chemotherapy

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 3, 2010, Pages 759-761

  Akhsan, Alfiyannul ^a   Aryandono, Teguh ^a  

^a GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

Clinical stage; ER PR; HER 2; Histological grade; Indonesia; Locally advanced breast cancer

Indexed keywords

EID: 78650696921     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Beeghly FA, Kataoka N, Shu XO, et al. (2008). Her-2/neu amplification and breast cancer survival: results from the Shanghai breast cancer study. Oncol Rep, 19, 1347-54.
2. Chang HR, Prati R, Gornbrin JA, et al. (2009). Breast cancerlocal regional and adjuvant therapy. J Clin Oncol, (abstract e 11573).
3. Clark GM. (2000). Prognosis and Predictive Factors. In: Harris Jr, Lippman ME, Morrow M, Osborn CK. Disease of the Breast, second edition. Philadelphia, 328-423.
4. Coleman MP. (2001). Trends and socioeconomic inequalities in England and Wales up to 2001. (http://infocancerresearchhuk.org/cancerstats/types/breast/survival.com).
5. Giardano SH. (2003). Update on locally advanced breast c ancer. Oncologist, 8, 521-30.
6. Pasqualini JR, Sparano JA cit Goldhirch. (2003). Breast cancer: prognostic, therapy and preventive. 24, 493-508.
7. Rakha EA, El-Sayed ME, Green AR. (2007). Prognostic markers in triple-negative breast cancer. Cancer, 109, 25-32.
8. Roth SL. (2009). Survival advantage by neoadjuvant radiochemotherapy in locally advanced non inflammatory breast cancer. J Clin Oncol, 27, 638.
9. Rustogi A, Budrukkar A, Dinshaw K, et al. (2005). Management of locally advanced breast cancer; Evolution and current practice. JCRT, 1, 21-30.
10. Schniff SJ, Guidi AJ. (2000). Pathology and Biological Markers of Invasive Breast Cancer. In: JR Harris, ME Lippman, M Morrow & CK Osborne (eds). Diseases of The Breast (2nd ed), 425-70.